Fibronostics Overview
- Founded
-
2015
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$6.5M
- Investors
-
6
Fibronostics General Information
Description
Developer of a non-invasive diagnostic testing system designed to provide algorithm-based health monitoring services. The company's system focuses on assessing liver disease existence/progression and chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea, enabling doctors to detect any early signs in order to facilitate efficient monitoring of diseases.
Contact Information
Website
www.fibronostics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Diagnostic Equipment
Primary Office
- 274 East Eau Gallie Boulevard
- Suite - 346
- Indian Harbour Beach, FL 32937
- United States
+1 (888) 000-0000
Fibronostics Timeline
Fibronostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series A) | 15-Jun-2022 | $6.5M | 000.00 | Completed | Generating Revenue | |
| 3. Later Stage VC (Series A) | 24-Aug-2020 | 000 | 000 | Completed | Generating Revenue | |
| 2. Early Stage VC | 31-May-2019 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 01-Jan-2018 | Completed | Generating Revenue |
Fibronostics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a non-invasive diagnostic testing system designed to provide algorithm-based health monitoring services. Th
Decision/Risk Analysis
Indian Harbour Beach, FL
13
As of 2022
000.00
00000000000
000.00
000000
dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000000000 000000000
Berlin, Germany
0000
As of 0000
0000
0000-00-00
000000&0
000000
inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000 000000000
New Delhi, India
0
As of 0000
00.000
0.000
0000-00-00
00000000000
00.000
Add Comparison
Fibronostics Competitors (7)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Biotronik | Corporate Backed or Acquired | Berlin, Germany | 0000 | 000000&0 | ||
| 000000 | Venture Capital-Backed | New Delhi, India | 0 | 00.000 | 00000000000 | 00.000 |
| 000 00000 00000000 | Corporation | New York, NY | 0 | 00000000 | ||
| 0000000 0000000 | Corporate Backed or Acquired | Brea, CA | 00000 | 000000&0 | ||
| 00000 (0000000000 | Venture Capital-Backed | Toronto, Canada | 00 | 00.000 | 000000000 | 00.000 |
Fibronostics Executive Team (14)
Fibronostics Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Aditya Mathur | Elev8.VC | Board Member | 000 0000 |
| Laurent Benissan | SPRIM Ventures | Board Member | 000 0000 |
| Michael Shleifer Ph.D | Self | Co-Founder & Board Member | 000 0000 |
| Neil Parekh | Tikehau Capital | Board Member | 000 0000 |
| Olivier Shleifer Ph.D | Fibronostics | Co-Founder & Board Member | 000 0000 |
Fibronostics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Fibronostics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| AT Capital Group | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Elev8.VC | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Ayala Healthcare Holdings | Corporation | Minority | 000 0000 | 000000 0 | |
| Vigos | Corporation | Minority | 000 0000 | 000000 0 | |
| SPRIM Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |